About
Vision
To keep all eyes healthy in our digitised world.
Mission
Empowering people to achieve their best vision and eye health through education & science driven technological solutions.
About us
Founded in 2017 and with the support of the Singapore National Eye Centre, Singapore Eye Research Institute and National Health Innovation Centre, Plano launched the world’s first science-based parental control application, planoApp, with a vision to “Keep all eyes healthy in our digitised world”.
With more than 1.5 billion people suffering from myopia, also known as short-sightedness, the number is expected to rise to 5 billion by 2050. Plano aims to tackle this epidemic that could see 1 billion people (by 2050) developing high myopia, which can lead to blindness. Studies have shown that excessive smart device use is a key contributing factor.
While we support the advances and uptake of technology, we believe in building safe and healthy relationships with devices. At Plano, we offer innovative solutions that better manage smart device use to improve eye health. As an official partner of the National Myopia Prevention Program in Singapore, Plano continues to innovate and participate in driving this initiative.
Today, Plano has an ecosystem comprising education and awareness, technological solutions and Artificial Intelligence (AI), that offers a wide range of eye health wellness solutions for all kids, parents and adults.
Our Team
Meet the people taking up the fight against myopia.
Founder
Associate Professor Mo Dirani
Associate Professor Mo Dirani completed his PhD at the University of Melbourne, his MBA at the Australian Institute of Business (AIB) and is a graduate from the Australian Institute of Company Directors (AICD). He is an adjunct Associate Professor at the Duke-NUS Medical School and also holds honorary Principal Investigator positions at the Singapore Eye Research Institute (SERI), Singapore, and Centre for Eye Research Australia (CERA), Australia.
Advisory & Board of Directors
Kuni Furuyama
Kuni Furuyama is the Head of Vision Social Innovation at Santen Pharmaceutical Co. Ltd . He has more than 25 years of experience in Corporate Strategy, Corporate Finance and M & A that spans across the healthcare, telecom, energy, real estate and electronics industries. He completed his Sloan Fellowship MSc in Management at London Business School.
Daniel Tan
Daniel is an English and Singapore qualified solicitor with over 15 years’ experience in cross-border and domestic corporate and banking law. The areas of his experience span from syndicated loans, structured finance to note issuances and regulatory matters.
Professor Jonathan Crowston
Professor Crowston is a clinician-scientist and Professor of Ophthalmology at the Duke-NUS Medical School. He was the former Managing Director of the Centre for Eye Research Australia, Melbourne, Australia. He is a practising Ophthalmologist and leads world class translational research in glaucoma.
Chan Lay Hoon
Lay Hoon is the Chairman of RSP Holdings Pte Ltd, a leading architectural and engineering practices in Singapore and the region. She also sits on the board of McLaren Group Limited and the Singapore Olympic Foundation. She was the Executive Chairman of Thomson Medical group from 2010-2014 and Chairman and Executive President of Valencia Club de Futbol S.A.D. from 2015-2017.
Executive Team
Kevin Tay, COO
Kevin is an MBA graduate from the Nanyang Business School, with a double degree in Strategy and International Management from the University of St. Gallen, Switzerland. Kevin read his undergraduate studies in Chemical Engineering from the National University of Singapore (NUS).
Cliff Chai, CFO
Cliff Chai is a CFA charterholder who graduated from the National University of Singapore with a honours degree in Civil Engineering. He has more than 18 years of industry experience spanning the Healthcare, Construction and Finance sectors. Prior to joining plano, he was a senior partner at a boutique corporate advisory outfit.
Kelvin Li, CTO
Over the last 15 years, Kelvin has done excellent work in scaling up the IT capabilities of both corporates and start-ups to be the best in their class. Prior to plano, Kelvin held various leadership positions and played an integral role in a start-up eventually listed on the mainboard of SGX.
Science & Innovation Advisory
Professor Wong Tien Yin, Chairman
Deputy Group CEO (Research & Education), SingHealth | Vice Dean, Academic & Clinical Development, Duke-NUS Medical School | Provost’s Chair Professor, National University of Singapore | Medical Director & Senior Consultant Ophthalmologist, Singapore National Eye Centre | Chair, Ophthalmology and Visual Sciences Academic Clinical Programme | Chairman, Board of Directors, Singapore Eye Research Institute | Elected member of the National Academy of Medicine in the United States.
Professor Wong is a retinal specialist with a clinical practice focusing on major retinal diseases, and leads nation-wide research studies. He has published >1,000 peer-reviewed papers, given >300 invited plenary, symposium and named lectures globally.